Long-term complete remission in a multiple myeloma patient after Stevens-Johnson syndrome due to lenalidomide therapy

Acta Oncol. 2013 Jun;52(5):1050-1. doi: 10.3109/0284186X.2012.732706. Epub 2012 Nov 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Female
  • Humans
  • Immunologic Factors / adverse effects*
  • Lenalidomide
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Stevens-Johnson Syndrome / chemically induced*
  • Stevens-Johnson Syndrome / immunology
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*

Substances

  • Immunologic Factors
  • Thalidomide
  • Lenalidomide